Sangart is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. During more than 30 years of extensive research, Sangart has refined the pegylation of human hemoglobin to create a proprietary molecule, MP4, with the ability to perfuse oxygen deprived tissues and carry oxygen through the circulatory system to prevent and treat ischemia (oxygen deprivation of tissues).
|
|
|
|
|
11-50 employees
View all SANG.art employees
|
|
|
Biotechnology
|
|
|
Lusk Blvd,San Diego,CA,US
|
|
|
An Investigational Biopharmaceutical Designed To Enhance The Perfusion And Oxygenation Of Ischemic Tissues, Our Product Platform Is Based On The Mp4 Molecule
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.